The cryopreservation of high concentrated PBMC for dendritic cell (DC)-based cancer immunotherapy

Cryobiology

Volumn 58, Issue 2, 2009, Pages 203-209

  Heo, Yoon Jeong ^a   Son, Cheol Hun ^a   Chung, Joo Seop ^b   Park, You Soo ^a   Son, Jeong Hwa ^a  

^a Binex Co Ltd   (South Korea)

^b Pusan National University Hospital   (South Korea)

Author keywords

Cryopreservation; Dendritic cells; High concentrated PBMC; Immunotherapy

Indexed keywords

GAMMA INTERFERON; LIQUID NITROGEN;

ARTICLE; CANCER IMMUNOTHERAPY; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYOPRESERVATION; CYTOKINE RELEASE; DENDRITIC CELL; ENDOCYTOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FREEZING; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LYMPHOCYTE ACTIVATION; MIXED LYMPHOCYTE REACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; STORAGE TEMPERATURE;

CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CRYOPRESERVATION; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; TIME FACTORS;

EID: 60549092471     PISSN: 00112240     EISSN: 10902392     Source Type: Journal    
DOI: 10.1016/j.cryobiol.2008.12.006     Document Type: Article

References (36)

1. Adamson L., Palmborg A., Svensson A., Lundqvist A., Hansson M., Kiessling R., Masucci G., Mellstedt H., and Pisa P. Development of a technology platform for large-scale clinical grade production of DC. Cytotherapy 6 (2004) 363-371
2. Almici C., Ferremi P., Lanfranchi A., et al. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors. Haematologica 88 (2003) 1390-1395
3. Banchereau J., and Palucka K. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5 (2005) 296-306
4. Berzofsky J.A., Terabe M., Oh S., Belyakov I.M., Ahlers J.D., Janik J.E., and Morris J.C. Progress on new vaccine strategies for the immunotherapy and prevention of cancer. J. Clin. Invest. 113 (2004) 1515-1525
5. Best A., Hidalgo G., Mitchell K., and Yannelli J.R. Issues concerning the large scale cryopreservation of peripheral blood mononuclear cells (PBMC) for immunotherapy trials. Cryobiology 54 (2007) 294-297
6. Curti A., Isidori A., Ferri E., Terragna C., Neyroz P., Cellini C., Ratta M., Baccarani M., and Lemoli R.M. Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy. Leuk. Lymphoma 45 (2004) 1419-1428
7. Danciger J.S., Lutz M., Hama S., Cruz D., Castrillo A., Lazaro J., Phillips R., Premack B., and Berliner J. Method for large scale isolation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation. J. Immunol. Meth. 288 (2004) 123-134
8. Disis M.L., Rosa C., Goodell V., et al. Maximzing the retention of antigen specific lymphocyte function after cryopreservation. J. Immunol. Meth. 308 (2006) 13-18
9. Fong L., and Engleman E.G. Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 18 (2000) 245-273
10. Fowke K.R., Behnke J., Hanson C., Shea K., and Cosentino L.M. Apoptosis: a method for evaluating the cryopreservation of whole blood and peripheral blood mononuclear cells. J. Immunol. Meth. 244 (2000) 139-144
11. Ghanekar S.A., Bhatia S., Ruitenberg J.J., Rosa C.D., Disis M.L., Maino V.C., Maecker H.T., and Waters C.A. Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors. J. Immune. Based Ther. Vaccines 5 (2007) 1-14
12. Gilboa E. DC-based cancer vaccines. J. Clin. Invest. 117 (2007) 1195-1203
13. Goto S., Kaneko T., Miyamoto Y., Eriguchi M., Kato A., Akeyama T., Fujimoto K., Tomonaga M., and Egawa K. Combined immunocell therapy using activated lymphocytes and monocyte-derived dendritic cells for malignant melanoma. Anticancer Res. 25 (2005) 3741-3746
14. Halle P., Tournilhac O., Knopinska-Poluszny W., et al. Uncontrolled-rate freezing and storage at -80 °C, with only 3.5-percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cells transplantation. Transfusion 41 (2001) 667-673
15. Higuchi R., Yamamoto M., Hatori T., Shimizu K., Imai K., and Takasaki K. Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case. Surg. Today. 36 (2006) 559-562
16. Hori S., Heike Y., Takei M., et al. Freeze-thawing procedures have no influence on the phenotypic and functional development of dendritic cells generated from peripheral blood CD14+ monocytes. J. Immunother. 27 (2004) 27-35
17. Jeras M., Bergant M., and Repnik U. In vitro preparation and functional assessment of human monocyte-derived dendritic cells - potential antigen-specific modulators of in vivo immune responses. Transpl. Immunol. 14 (2005) 231-244
18. Kleeberger C.A., Lyles R.H., Margolick J.B., Rinaldo C.R., Phair J.P., and Giorgi J.V. Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study. Clin. Diagn. Lab. Immunol. 6 (1999) 14-19
19. Kover L. Nalgene Cryopreservation Manual (1991), Nalge, Rochester, NY
20. Macary P.A., Too C.T., and Dai X. Targeting tumors by adoptive transfer of immune cells. Clin. Exp. Pharmacol. Physiol. 33 (2006) 569-574
21. Makino M., and Baba M. A cryopreservation method of human peripheral blood mononuclear cells for efficient production of dendritic cells. Scand. J. Immunol. 45 (1997) 618-662
22. Matsushita N., Kobayashi Y., Tanaka Y., Nakao M., Shimizu K., Takeshita N., Tanigawa K., and Aruga A. Combined cell therapy by using dendritic cells, T-cells and NK cells to human polymorphic cancer. Gan To Kagaku Ryoho. 31 (2004) 1655-1658
23. Meehan K.R., Wu J., Ernstoff M.S., Webber S.M., Barber A., Szczepiorknowski Z.M., and Sentman C. Development of a clinical model for ex vivo expansion of multiple populations of effector cells for adoptive cellular therapy. Cytotherapy 10 (2008) 30-37
24. Montanari M., Capelli D., Poloni A., et al. Long-term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlled-rate freezing and uncontrolled-rate freezing at 80 °C. Transfusion 43 (2003) 42-49
25. Peng B.G., Liang L.J., He Q., Huang J.F., and Lu M.D. Expansion and activation of natural killer cells from PBMC for immunotherapy of hepatocellular carcinoma. World J. Gastroenterol. 10 (2004) 2119-2123
26. Reimann K.A., Chernoff M., Wilkening C.L., Nickerson C.E., and Landay A.L. Preservation of lymphocyte immunophenotype and proliferative response in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors. Clin. Diagn. Lab. Immunol. 7 (2000) 352-359
27. Riccio E.K.P., Jr I.N., Banic D.M., Real S.C., Alecrim M.G., Morgado M., Ribeiro C.T.D., and Cruz M.F.F. Cryopreservation of peripheral blood mononuclear cells does not significantly affect the levels of spontaneous apoptosis after 24-h culture. Cryobiology 45 (2002) 127-134
28. Ridgway D. The first 1000 dendritic cell vaccines. Cancer Invest. 21 (2003) 873-886
29. Steinman R.M., and Dhodapkar M. Active immunization against cancer with dendritic cells: the near future. Int. J. Cancer 94 (2001) 459-473
30. Thurner B., Röder C., Dieckmann D., Heuer M., Kruse M., Claser A., Keikavoussi P., Kämpgen E., Bender A., and Schuler G. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J. Immunol. Meth. 223 (1999) 1-15
31. Turin I., Pedrazzoli P., Tullio C., Montini E., La Grotteria M.C., Schiavo R., Perotti C., Locatelli F., Carretto E., Maccario R., Siena S., and Montagna D. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia. Cytotherapy 9 (2007) 499-507
32. Tuyaerts S., Noppe S.M., Corthals J., Breckpot K., Heirman C., Greef C.D., Riet I.V., and Thielemans K. Generation of large numbers of dendritic cells in a closed system using cell factories™. J. Immunol. Meth. 264 (2002) 135-151
33. Weinberg A., Louzao R., Mussi-Pinhata M.M., Cruz M.L.S., Pinto J.A., Huff M.F., Castro A.C., Sucupira M.C., and Denny T.N. Quality assurance program for peripheral blood mononuclear cell cryopreservation. Clin. Vaccine. Immunol. 14 (2007) 1242-1244
34. Westermann J., Koerner I.J., Kopp J., Kurz S., Zenke M., Doerken B., and Pezzutto A. Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties. Cancer Immunol. Immunother. 52 (2003) 194-198
35. Wu J.Y., Ernstoff M.S., Hill J.M., Cole B., and Meehan K.R. Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma. Cryotherapy 8 (2006) 141-148
36. Yannelli J.R., and Wroblewski J.M. On the road to a tumor cell vaccine, 20 years of cellular immunotherapy. Vaccine 23 (2004) 97-113